Oxagen, University of Warwick Win 2M Grant for Genome-Wide GPCR Research | GenomeWeb

NEW YORK, March 6 - UK-based Oxagen and The University of Warwick have jointly won a grant for £2 million, or $3 million, to chart genome-wide functional variation in the genes for G-protein coupled receptors.

The three-year grant from the LINK Applied Genomics Programme will bring together yeast-based systems developed at Warwick for high-throughput GPCR-function analysis with Oxagen's experience in large-scale genetic analysis.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.